• 1. Using weak interactions to control C–H mono-nitration of indolines
  Anima Bose,Prasenjit Mal Chem. Commun. 2017 53 11368
• 2. Metal-free regioselective C-3 acetoxylation of N-substituted indoles: crucial impact of nitrogen-substituent
  Vineeta Soni,Ulhas N. Patel,Benudhar Punji RSC Adv. 2015 5 57472
• 3. Self-assembly of alkyl N-acetylglyoxylic amides of varying chain lengths
  Venty Suryanti,Mohan Bhadbhade,Roger Bishop,David StC Black,Naresh Kumar CrystEngComm 2012 14 7345
• 4. β-Oxodithioesters: a new frontier for diverse heterocyclic architectures
  Maya Shankar Singh,Ganesh Chandra Nandi,Tanmoy Chanda RSC Adv. 2013 3 14183
• 5. A rapid and clean synthetic approach to cyclic peptides via micro-flow peptide chain elongation and photochemical cyclization: synthesis of a cyclic RGD peptide
  Yuto Mifune,Hiroyuki Nakamura,Shinichiro Fuse Org. Biomol. Chem. 2016 14 11244

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives

1-(2,3-dihydro-1H-indol-1-yl)ethan-1-one (CAS No. 16078-30-1): An Overview of Its Structure, Properties, and Applications in Medicinal Chemistry

1-(2,3-dihydro-1H-indol-1-yl)ethan-1-one, also known by its CAS number 16078-30-1, is a versatile compound with significant applications in medicinal chemistry and pharmaceutical research. This compound, commonly referred to as indanone, is a derivative of indole and exhibits a unique combination of structural features that make it an attractive candidate for various biological and therapeutic studies.

The molecular structure of 1-(2,3-dihydro-1H-indol-1-yl)ethan-1-one consists of a substituted indole ring fused with a ketone group. The indole ring is a fundamental building block in many biologically active compounds, including neurotransmitters and natural products. The presence of the ketone group adds reactivity and functional versatility, making this compound a valuable intermediate in the synthesis of more complex molecules.

In recent years, the study of 1-(2,3-dihydro-1H-indol-1-yl)ethan-1-one has gained considerable attention due to its potential therapeutic applications. Research has shown that this compound and its derivatives exhibit a range of biological activities, including anti-inflammatory, analgesic, and neuroprotective properties. These findings have sparked interest in exploring the compound's potential as a lead molecule for drug development.

One notable area of research involves the use of 1-(2,3-dihydro-1H-indol-1-yl)ethan-1-one in the treatment of neurodegenerative diseases. Studies have demonstrated that certain derivatives of this compound can modulate key signaling pathways involved in neuronal survival and function. For example, a recent study published in the Journal of Medicinal Chemistry reported that a specific derivative of 1-(2,3-dihydro-1H-indol-1-yl)ethan-1-one showed promising neuroprotective effects in an animal model of Parkinson's disease.

The pharmacological profile of 1-(2,3-dihydro-1H-indol-1-yl)ethan-1-one is further enhanced by its ability to cross the blood-brain barrier (BBB). This property is crucial for drugs targeting central nervous system (CNS) disorders, as it ensures that the compound can reach its intended site of action within the brain. Researchers have utilized this characteristic to develop novel drug delivery systems that improve the bioavailability and efficacy of 1-(2,3-dihydro-1H-indol-1-yl)ethan-1-one-based therapeutics.

Beyond its therapeutic applications, 1-(2,3-dihydro-1H-indol-1-y l)ethan - ione has also been studied for its role in chemical biology. The compound serves as a useful tool for probing cellular processes and signaling pathways. For instance, it has been used to investigate the regulation of protein kinases and their involvement in various cellular functions. This research has provided valuable insights into the mechanisms underlying disease pathogenesis and has opened new avenues for drug discovery.

The synthetic accessibility of 1-(2,3-dihydro- 1H -indol - 0ne)-y l ethan - ione is another factor contributing to its widespread use in scientific research. Various synthetic routes have been developed to produce this compound efficiently and cost-effectively. One common method involves the condensation of indole with an appropriate ketone or aldehyde followed by reduction steps to form the desired product. These synthetic strategies have facilitated the preparation of large quantities of 0ne)-y l ethan - ione-based compounds for both academic and industrial applications.

In conclusion, yl ethan - ione), with its CAS number (CAS No. (CAS No. ), is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features, combined with its diverse biological activities and synthetic accessibility, make it an attractive candidate for further exploration and development as a therapeutic agent.

• 62368-29-0(1-(6-amino-2,3-dihydro-1H-indol-1-yl)ethan-1-one)
• 21905-78-2(Acetyloxindole)
• 16078-35-6(1,1'-(Indoline-1,5-diyl)diethanone)
• 2861-59-8(2,3-dihydro-1H-indole-1-carbaldehyde)
• 61-70-1(1-Methyl-2-oxindole (1-Methyl-2-indolone))
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)